H

Huons Co Ltd
KOSDAQ:243070

Watchlist Manager
Huons Co Ltd
KOSDAQ:243070
Watchlist
Price: 27 350 KRW -0.18% Market Closed
Market Cap: 327.7B KRW

Relative Value

The Relative Value of one Huons Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 27 350 KRW, Huons Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Huons Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
82
Median 3Y
0.7
Median 5Y
0.8
Industry
2.6
Forward
0.5
vs History
80
vs Industry
38
Median 3Y
9.7
Median 5Y
10.5
Industry
21.4
Forward
7.4
vs History
82
vs Industry
46
Median 3Y
6.4
Median 5Y
8.5
Industry
16.4
vs History
52
vs Industry
26
Median 3Y
12.2
Median 5Y
12.2
Industry
22.8
vs History
87
vs Industry
63
Median 3Y
1.1
Median 5Y
1.3
Industry
2.2
vs History
87
vs Industry
81
Median 3Y
0.7
Median 5Y
0.8
Industry
2.9
Forward
0.6
vs History
80
vs Industry
79
Median 3Y
1.4
Median 5Y
1.5
Industry
5.5
vs History
93
vs Industry
43
Median 3Y
6
Median 5Y
6.5
Industry
13
Forward
5.1
vs History
88
vs Industry
39
Median 3Y
8.5
Median 5Y
9.3
Industry
16.5
Forward
7.8
vs History
87
vs Industry
44
Median 3Y
7.2
Median 5Y
8.4
Industry
15.6
vs History
52
vs Industry
3
Median 3Y
-12.3
Median 5Y
41
Industry
18.7
vs History
93
vs Industry
67
Median 3Y
0.9
Median 5Y
1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Huons Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Huons Co Ltd
KOSDAQ:243070
318.7B KRW 0.5 9.1 5.4 8
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.3 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
KR
H
Huons Co Ltd
KOSDAQ:243070
Average P/E: 22.6
9.1
16%
0.6
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
H
Huons Co Ltd
KOSDAQ:243070
Average EV/EBITDA: 400.3
5.4
10%
0.5
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
H
Huons Co Ltd
KOSDAQ:243070
Average EV/EBIT: 1 712.8
8
13%
0.6
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5